GSK3β/eEF2K信号通路对小鼠肺纤维化过程的影响*

doi:10.12047/j.cjap.6201.2022.006

摘要/Abstract

摘要： 目的: 探讨糖原合成酶激酶-3(GSK3β)/真核延伸因子激酶2(eEF2K)信号通路对肺纤维化进程的影响,为临床治疗肺纤维化寻找新的思路。方法: 采用一次性气管注射法构建C57BL/6雄性小鼠博莱霉素肺纤维化模型,造模14 d后将动物分成模型组、阴性抑制组与抑制组(n=5),另设空白组不作处理。抑制组使用腹腔注射TDZD-8(4 mg/kg),阴性抑制组腹腔注射二甲基亚砜(DMSO)溶液,28 d后处死采集指标。采用苏木精-伊红染色法检测小鼠肺脏病变情况;试剂盒水解法检测肺组织中羟脯氨酸(Hyp)的含量;采用Western blot法检测肺脏中GSK3β、磷酸化GSK3β(p-GSK3β)、eEF2K、p-eEF2K(Ser70)、p-eEF2K(Ser392)、p-eEF2K(Ser470)、基质金属蛋白酶-2前体蛋白(pro-MMP-2)、基质金属蛋白酶-2(MMP-2)蛋白表达水平,使用免疫组织化学法检测肺脏中MMP-2、胶原蛋白I(Col I)、胶原蛋白Ⅲ(Col Ⅲ)、α-平滑肌蛋白(α-SMA)的表达。结果: 与空白组相比,模型组中GSK3β、p-GSK3β、p-eEF2K(Ser70)、p-eEF2K(Ser392)、p-eEF2K(Ser470)、pro-MMP-2、MMP-2、Col I、Col Ⅲ、α-SMA蛋白表达水平升高,eEF2K蛋白表达水平降低(P＜0.05);与模型组相比,抑制组GSK3β、p-GSK3β、p-eEF2K(Ser70)、p-eEF2K(Ser392)、p-eEF2K(Ser470)、pro-MMP-2、MMP-2、Col I、Col Ⅲ、α-SMA蛋白表达降低,eEF2K蛋白表达升高(P＜ 0.05)。结论: GSK3β能通过Ser70、Ser392、Ser470这3个位点磷酸化激活eEF2K,增加纤维化指标含量,促进肺纤维化形成,加重肺组织病变。

关键词: 肺纤维化, 小鼠, GSK3β/eEF2K, MMP-2, TDZD-8

Abstract: Objective: To investigate the effects of glycogen synthase kinase-3β (GSK3β)/eukaryotic extension factor kinase 2 (eEF2K) signaling pathway on the process of pulmonary fibrosis through in vivo experiments, and find new ideas for clinical treatment of pulmonary fibrosis. Methods: The pulmonary fibrosis model of C57BL/6 male mice was induced by bleomycin with intratracheal injection at the dose of 2 mg/kg. After 14 days of modeling, animals were divided into model group, negative inhibition group and inhibition group (n=5 for each group), and control group was not processed. The inhibition group was treated with TDZD-8 (4 mg/kg) after modeling, the negative inhibition group was given DMSO solution after modeling, and the samples were collected after 28 days. Hematoxylin-eosin staining method was used to detect lung fibrosis in mice and scored according to Ashcroft scale. Expression levels of GSK3β, p-GSK3β, eEF2K, p-eEF2K (Ser70, Ser392, Ser470), precursor protein of matrix metalloproteinase-2 (pro-MMP-2), matrix metalloproteinase-2 (MMP-2), collagen I (Col I), collagen Ⅲ (Col Ⅲ) and α-smooth muscle actin (α-SMA) were detected by Western blot. Results: Compared with control group, the fibrosis score was up-regulated, the expression levels of GSK3β, p-GSK3β, p-eEF2K (Ser70, Ser392, Ser470), pro-MMP-2, MMP-2, Col I, Col Ⅲ and α-SMA were increased, while that of eEF2K was decreased in model group (P＜0.05). Compared with model group, the fibrosis score, expression levels of GSK3β, p-GSK3β, p-eEF2K (Ser70, Ser392, Ser470), pro-MMP-2, MMP-2, Col I, Col Ⅲ and α-SMA were decreased, but the expression level of eEF2K was increased in inhibition group (P＜0.05). Conclusion: GSK3β can activate eEF2K by phosphorylation at the sites of Ser70, Ser392 and Ser470, increase the contents of fibrosis indicators, promote the formation of pulmonary fibrosis, and aggravate lung tissue lesions.

Key words: pulmonary fibrosis, mice, GSK3β/eEF2K, MMP-2, TDZD-8

中图分类号:

R563

覃超群, 黄斌, 阳芳, 王昌明, 肖影, 莫艳菊, 廖艺, 高枫. GSK3β/eEF2K信号通路对小鼠肺纤维化过程的影响^*[J]. 中国应用生理学杂志, 2022, 38(1): 32-36.

QIN Chao-qun, HUANG Bin, YANG Fang, WANG Chang-ming, XIAO Ying, MO Yan-ju, LIAO Yi, GAO Feng. Effects of GSK3β/eEF2K signaling pathway on pulmonary fibrosis in mice[J]. CJAP, 2022, 38(1): 32-36.

参考文献

[1] Varone F, Mastrobattista A, Franchi P, et al. Pulmonary fibrolysis in a patient with idiopathic pulmonary fibrosis: improvement of clinical and radiological pattern after treatment with pirfenidone[J]. Clin Respir J, 2018, 12(1): 347-351.
[2] Kim HS, Yoo HJ, Lee KM, et al. Stearic acid attenuates profibrotic signalling in idiopathic pulmonary fibrosis[J]. Respirology, 2020, 26(3): 255-263.
[3] Raghu G, Wells AU, Nicholson AG, et al. Effect of nintedanib in subgroups of idiopathic pulmonary fibrosis by diagnostic criteria[J]. Am J Respir Crit Care Med, 2017, 195(1): 78-85.
[4] Birjandi SZ, Palchevskiy V, Xue YY, et al. CD4(+)CD25(hi)Foxp3(+) cells exacerbate bleomycin-induced pulmonary fibrosis[J]. Am J Pathol, 2016, 186(8): 2008-2020.
[5] Proud CG. Regulation and roles of elongation factor 2 kinase[J]. Biochem Soc Trans, 2015, 43(3): 328-332.
[6] Kameshima S, Kazama K, Okada M, et al. Eukaryotic elongation factor 2 kinase mediates monocrotaline-induced pulmonary arterial hypertension via reactive oxygen species-dependent vascular remodeling[J]. Am J Physiol Heart Circ Physiol, 2015, 308(10): 1298-1305.
[7] Gurrieri C, Piazza F, Gnoato M, et al. 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a glycogen synthase kinase-3 inhibitor, displays therapeutic properties in a mouse model of pulmonary inflammation and fibrosis[J]. J Pharmacol Exp Ther, 2010, 332(3): 785-794.
[8] Greco F, Wiegert S, Baumann P, et al. Hyperoxia-induced lung structure-function relation, vessel rarefaction, and cardiac hypertrophy in an infant rat model[J]. J Transl Med, 2019, 17(1): 91.
[9] Ni S, Wang D, Qiu X, et al. Bone marrow mesenchymal stem cells protect against bleomycin-induced pulmonary fibrosis in rat by activating Nrf2 signaling[J]. Int J Clin Exp Pathol, 2015, 8(7): 7752-7761.
[10] Zhou XL, Xu P, Chen HH, et al. Thalidomide inhibits TGF-β1-induced epithelial to mesenchymal transition in alveolar epithelial cells via Smad-dependent and Smad-independent signaling pathways[J]. Sci Rep, 2017, 7(1): 14727.
[11] Keller JL, Housh TJ, Hill EC, et al. The effects of Shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels[J]. J Int Soc Sports Nutr, 2019, 16(1): 3.
[12] Fu Y, Zhao P, Xie Z, et al. Oridonin inhibits myofibroblast differentiation and bleomycin-induced pulmonary fibrosis by regulating transforming growth factor β (TGFβ)/Smad pathway[J]. Med Sci Monit, 2018, 24(1): 7548-7555.
[13] 陈彦凡, 何以成, 黄卡特, 等. 腺苷A_(2a)受体在博莱霉素诱导的小鼠肺纤维化中的作用[J]. 中国应用生理学杂志, 2018, 34(3): 204-208.
[14] Srivastava AK, Khare P, Nagar HK, et al. Hydroxyproline: A potential biochemical marker and its role in the pathogenesis of different diseases[J]. Curr Protein Pept Sci, 2016, 17(6): 596-602.
[15] 卢林明, 俞婷婷, 何晓伟, 等. 小剂量辣椒素抗小鼠肺纤维化的作用及其机制[J]. 中国应用生理学杂志, 2020, 36(3): 216-222.
[16] Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting[J]. FEBS J, 2011, 278(1): 16-27.
[17] Cheng MH, Wong YH, Chang CM, et al. B1, a novel HDAC inhibitor, induces apoptosis through the regulation of STAT3 and NF-κB[J]. Int J Mol Med, 2017, 39(5): 1137-1148.
[18] 肖雪, 李龙. 基质金属蛋白酶与特发性肺纤维化关系研究进展[J]. 河北医药, 2020, 42(22): 3462-3467.
[19] Karakas D, Ozpolat B. Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target[J]. J Mol Med (Berl), 2020, 98(6): 775-787.
[20] Moore CE, Wang X, Xie J, et al. Elongation factor 2 kinase promotes cell survival by inhibiting protein synthesis without inducing autophagy[J]. Cell Signal, 2016, 28(4): 284-293.
[21] Wang Y, Huang G, Wang Z, et al. Elongation factor-2 kinase acts downstream of p38 MAPK to regulate proliferation, apoptosis and autophagy in human lung fibroblasts[J]. Exp Cell Res, 2018, 363(2): 291-298.
[22] Liu R, Proud CG. Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases[J]. Acta Pharmacol Sin, 2016, 37(3): 285-294.
[23] Bircan HA, Gurbuz N, Pataer A, et al. Elongation factor-2 kinase (eEF-2K) expression is associated with poor patient survival and promotes proliferation, invasion and tumor growth of lung cancer[J]. Lung Cancer, 2018, 124: 31-39.
[24] Wang X, Regufe Da Mota S, Liu R, et al. Eukaryotic elongation factor 2 kinase activity is controlled by multiple inputs from oncogenic signaling[J]. Mol Cell Biol, 2014, 34(22): 4088-4103.
[25] 许春花, 王永双, 金福, 等. 西地那非通过AKT/GSK3β信号通路保护小鼠肾纤维化的作用机制[J]. 医学研究生学报, 2020, 33(6): 592-597.
[26] Beretta S, Gritti L, Verpelli C, et al. Eukaryotic elongation factor 2 kinase a pharmacological target to regulate protein translation dysfunction in neurological diseases[J]. Neuroscience, 2020, 445(1): 42-49.

GSK3β/eEF2K信号通路对小鼠肺纤维化过程的影响^*

Effects of GSK3β/eEF2K signaling pathway on pulmonary fibrosis in mice

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	郝凯敏, 刘镇, 王浩玉, 祁文秀. PTK2B与Aβ、Tau和LRP-1在APP/PS1小鼠海马组织和血液中的表达随月龄变化的分析^*[J]. 中国应用生理学杂志, 2022, 38(1): 17-24.
[2]	马媛, 荀敬, 王波涛, 李棣华, 张琦, 王震宇, 吴瑜. 旋覆代赭汤对食管癌细胞干性的影响^*[J]. 中国应用生理学杂志, 2022, 38(1): 62-67.
[3]	汤娟, 柯洁, 付裕, 何晓伟, 李先伟. Ⅱ型肺泡上皮细胞间质转分化中的Notch-1/ Twist-1信号通路机制^*[J]. 中国应用生理学杂志, 2021, 37(6): 577-583.
[4]	白林林, 王志华, 宁学聪, 巩翠珂, 李爱敏, 段玉玲, 焦雨佼. IL-17A对慢性阻塞性肺疾病的干预作用及其机制^*[J]. 中国应用生理学杂志, 2021, 37(6): 584-588.
[5]	薛峰, 王辉, 许思多, 刘首挺, 龚永生, 范小芳. 左旋卡尼汀对脂多糖诱导小鼠肺微血管内皮细胞自噬和凋亡的影响^*[J]. 中国应用生理学杂志, 2021, 37(6): 589-593.
[6]	李莉, 黄涵柽. 莱菔子乙醇提取物对ApoE^-/-小鼠血脂血糖及肝脂肪变性的影响^*[J]. 中国应用生理学杂志, 2021, 37(6): 622-627.
[7]	胡佳楠, 姜辉, 李美琦, 朱俐, 骆倩倩. 模拟高原低氧环境对小鼠脾脏铁代谢的影响^*[J]. 中国应用生理学杂志, 2021, 37(6): 628-631.
[8]	李萍, 梁琳琅, 王宇, 侯达, 杨昕, 杨博. 二甲双胍和西格列汀对胰岛素抵抗糖尿病前期KKAy小鼠胰岛β细胞功能的影响^*[J]. 中国应用生理学杂志, 2021, 37(6): 644-649.
[9]	袁前发, 何珏, 徐志忠, 林多朵, 朱敬敬, 温春燕, 段海珍, 王文强. 重复经颅磁刺激联合低剂量氟西汀对CUMS抑郁小鼠的影响^*[J]. 中国应用生理学杂志, 2021, 37(6): 650-653.
[10]	谢文杰, 周刚, 李鹏飞, 杨帆, 安静芳, 李航. 游泳训练对小鼠心肌PKCδ/P66shc蛋白表达的影响^*[J]. 中国应用生理学杂志, 2021, 37(6): 688-693.
[11]	王小琴, 石卉, 方小霞, 彭聿平. α1-肾上腺素受体对胶原诱导性关节炎小鼠Treg细胞功能的影响^*[J]. 中国应用生理学杂志, 2021, 37(5): 449-453.
[12]	涂容芳, 何振华, 谭小武, 陈哲, 曾赛丽, 刘莎, 贾远航, 李雪花. 辛伐他汀对大鼠肺纤维化及其内皮间质变过程的影响^*[J]. 中国应用生理学杂志, 2021, 37(5): 454-459.
[13]	陈旭娥, 马婷, 盛良, 王文雯, 李季. IL-21单克隆抗体对MRL/lpr狼疮小鼠的治疗作用^*[J]. 中国应用生理学杂志, 2021, 37(5): 467-470.
[14]	贺英昊, 方情, 杨玲玲, 陈思敏, 骆燕萍, 钱虹, 齐敏友. 酮康唑对小鼠肝脏和睾丸生理功能的影响^*[J]. 中国应用生理学杂志, 2021, 37(5): 475-479.
[15]	臧茂林, 余梦迪, 陈重华, 黄梦琪, 罗鹏, 樊红琨, 杨春. 腹主动脉缩窄小鼠心脏结构和功能的动态变化^*[J]. 中国应用生理学杂志, 2021, 37(5): 479-482.